Addressing the Challenges of Progressive Multiple Sclerosis: Cases in Progressive MS
  • CME

Jiwon Oh, MD, PhD, FRCPC
James M. Stankiewicz, MD
Physicians: maximum of 0.5 AMA PRA Category 1 Credits
Released: August 30, 2019 Expiration: August 30, 2020

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Use diagnostic information to select appropriate management strategies for patients with SPMS.
  • Use diagnostic information to select appropriate management strategies for patients with PPMS.

Information on this Educational Activity

All faculty, staff and reviewers involved in the planning, review or presentation of continuing education activities provided by Purdue University College of Pharmacy are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. All additional planning committee members, staff and reviewers of MCM Education and Purdue University College of Pharmacy have no relationships to disclose.

Faculty

James M. Stankiewicz, MD

Assistant Professor of Neurology
Harvard Medical School
Clinical Director, Partners Multiple Sclerosis Center
Boston, Massachusetts

Dr. Stankiewicz discloses the following:

Consultant: EMD-Serono, Sanofi-Genzyme, Genentech

Advisory Board Membership: Novartis, Celgene, Biogen-Idec

Jiwon Oh, MD, PhD, FRCPC

Assistant Professor, Division of Neurology
St. Michael’s Hospital, University of Toronto
Assistant Professor, Department of Neurology
Johns Hopkins School of Medicine
Staff Neurologist, St. Michael’s Hospital
Scientist, Keenan Research Centre of the
Li Ka Shing Knowledge Institute
Toronto, Ontario

Dr. Oh discloses the following:

Grants/research support: Roche, Biogen-Idec, Sanofi-Genzyme

Consultant: Roche, Biogen-Idec, Sanofi-Genzyme, Celgene, EMD-Serono

Purdue University requires all faculty to disclose any planned discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.

In this educational activity, the faculty reports that their presentation will not contain reference to investigational and/or off-label uses.

Target Audience

Neurology clinicians (including physicians, NPs, PAs) and others who encounter patients with MS.

Physician Continuing Medical Education

Credit Statements

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Purdue University College of Pharmacy and MCM Education. Purdue University is accredited by the ACCME to provide continuing medical education for physicians.

Purdue University designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from August 30, 2019, through August 30, 2020:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 80% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Related Content

Concise CCO activity on selecting second-generation antipsychotics for treatment augmentation in patients with MDD and managing adverse events

Rakesh Jain, MD, MPH Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: May 7, 2020 Expired: May 6, 2021

Free slides from CCO and Rakesh Jain, MD, MPH: Expert insights on efficacy, role of antipsychotics in MDD, mitigating and manage adverse events

Rakesh Jain, MD, MPH Released: May 7, 2020

Free slides from CCO and Christoph U. Correll, MD: Expert insights on comorbidities in treatment augmentation for MDD

Christoph U. Correll, MD Released: April 13, 2020

Expert commentary on prevention and emerging treatment strategies for the COVID-19 pandemic from CCO

Daniel R. Kuritzkes, MD Released: March 19, 2020
Provided by
Purdue University Logo

Accreditation: Dawn Sinclair, Purdue University sinclaid@purdue.edu
Certificates/Credits: Heather Holley, Purdue University hholley@purdue.edu

This activity is supported by an educational grant from
Novartis Pharmaceuticals Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?